Last reviewed · How we verify

NCT04388020

Effects of Projected Peripheral Defocus on Ocular Biometrics

Completed NA Last updated 21 May 2021
What this trial tests

NA trial testing Tabletop prototype of eSpecs: Active projection of defocused image in the peripheral visual field in Myopia in 12 participants. Completed in 14 May 2020.

Timeline
11 April 2020
Primary endpoint
14 May 2020
14 May 2020

Quick facts

Lead sponsorKubota Vision Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment12
Start date11 April 2020
Primary completion14 May 2020
Estimated completion14 May 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Kubota Vision Inc. — full company profile →

Who can join

Adults 18 to 35, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery will stimulate physiological changes similar to those in the literature.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Kubota Vision Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04388020.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing